Mohammed Afif

Mohammed Afif

Auto-generated profile, based on publicly available information

Mohammed Afif

Université Mohamed V Souissi

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 June 2015 in World Journal of Surgical Oncology
Verified
Journal Article
Open access
PDF file
JKJihane Khalil
Jihane Khalil
BBBadr Bensaid
Badr Bensaid
HEHanan Elkacemi
Hanan Elkacemi
MAMohamed Afif
Mohamed Afif
YBYounes Bensaid
Younes Bensaid
NBNoureddine Benjaafar
Noureddine Benjaafar
Venous thromboembolism (VTE) is a major health problem among patients with cancer, its incidence in this particular population is widely increasing. Although VTE is associated with high rates of mortality and morbidity in cancer patients, its severity is still underestimated by many oncologists. Thromboprophylaxis of VTE now considered as a standard of care is still not prescribed in many institutions; the appropriate treatment of an established VTE is not yet well known by many physicians and nurses in the cancer field. Patients are also not well informed about VTE and its consequences. Many studies and meta-analyses have addressed this question so have many guidelines that dedicated a whole chapter to clarify and expose different treatment strategies adapted to this particular population. There is a general belief that the prevention and treatment of VTE cannot be optimized without a complete awareness by oncologists and patients. The aim of this article is to make VTE a more clear and understood subject.

1 May 2015 in Gynecologic Oncology Research and Practice
Verified
Journal Article
Open access
JKJ. Khalil
J. Khalil
SBS. Bellefqih
S. Bellefqih
NSN. Sahli
N. Sahli
MAM. Afif
M. Afif
HEH. Elkacemi
H. Elkacemi
NBN. Benjaafar
N. Benjaafar
Gynecologic Oncology Research and Practice is an open access, peer-reviewed journal publishing original research, reviews and reports on all cancers of the female reproductive system. Overseen by an expert international editorial board, the journal’s open access, online format, provides a high-visibility forum for oncologists, scientists and health care providers to discuss and share laboratory and clinical findings.

1 March 2017 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Closed access
SBSara Bellefqih
Sara Bellefqih
SESanaa Elmajjaoui
Sanaa Elmajjaoui
JAJihan Aarab
Jihan Aarab
JKJihane Khalil
Jihane Khalil
MAMohamed Afif
Mohamed Afif
NBNoureddine Benjaafar
Noureddine Benjaafar

1 July 2015 in Breast Cancer: Targets and Therapy
Verified
Journal Article
Open access
PDF file
FEFadwa Elomrani
Fadwa Elomrani
MZMaryam Zine
Maryam Zine
SLSaad L'Annaz
Saad L'Annaz
IOIimane Ouziane
Iimane Ouziane
HMHind Mrabti
Hind Mrabti
MMMohamed Afif Mohammed
Mohamed Afif Mohammed
Background: Breast cancer is a common condition. It is a leading cause of death among women, and its incidence increases with age. Aging of the population and improvement of the quality of life of elders make it a major public health issue. We reviewed the literature to try to determine the management of breast cancer in older women. Methods: We conducted a narrative review by literature searches using key words “breast cancer”, “elderly and older”, and “women” in Pubmed, Scopus, and Google Scholar. The aim of this review is to summarize the management of early breast cancer in older women by discussing the controversies of screening in older women. Then, we try to define the optimal strategy for these women, either surgery alone or primary endocrine therapy. We also discuss the indications of lymph node dissection, and we evaluate the benefit of adjuvant radiotherapy, chemotherapy, and the anti HER2 treatment for these women. Results: More than 50% of patients with breast cancer are 65 years or older, and around 30% are more than 70 years old. Most randomized trials did not include older women. Hence, the treatment of breast cancer in older patients is based on the management provided to younger women. Regardless of age, the treatment must aim for the best efficiency. Advanced age in itself should not be a limitation to treatment. There are no standard guidelines set for elderly patients. Surgical treatment for older patients evolved to avoid mastectomy, and conservative mammary surgery was proposed, similar to that used in younger patients. The proportion of elderly patients receiving adjuvant radiotherapy is increasing. The role of adjuvant radiotherapy in older patients with breast cancer was analyzed. Adjuvant chemotherapy is beneficial to women with hormone receptor-negative tumors. In those with hormone receptor-positive tumors, adjuvant chemotherapy in association to trastuzumab is beneficial for HER2-positive tumors, and for women with HER2-negative tumors adjuvant hormonal therapy is a very good option. Conclusion: Breast cancer is common in older women. This population requires particular and adapted management. It is essential for older patients to be included in new clinical trials for individualized treatment recommendation.

1 December 2016 in Revue D'Épidémiologie Et de Santé Publique
Verified
Journal Article
Closed access
LALachgar Amine
Lachgar Amine
MTM.A. Tazi
M.A. Tazi
MAM. Afif
M. Afif
AEA. Er-Raki
A. Er-Raki
TKT. Kebdani
T. Kebdani
NBN. Benjaafar
N. Benjaafar

19 March 2015 in Journal of Medical Case Reports
Verified
Journal Article
Open access
PDF file
JKJihane Khalil
Jihane Khalil
MAMohamed Afif
Mohamed Afif
HKHanan EL Kacemi
Hanan EL Kacemi
MBMeryem Benoulaid
Meryem Benoulaid
TKTayeb Kebdani
Tayeb Kebdani
NBNoureddine Benjaafar
Noureddine Benjaafar
Neurofibromatosis type 1, also known as Von Recklinghausen’s disease, is a rare neuroectodermal disease that mainly affects the skin and the nervous system. Patients with neurofibromatosis type 1 have a higher risk of developing various types of cancers, especially tumors derived from the embryogenic neural crest. However, its association with breast cancer has seldom been reported. We report the cases of three white Arabic women diagnosed with neurofibromatosis type 1, with a median age of 40-years-old (range: 39 to 43), who sought treatment at our centre for breast cancer. The association between neurofibromatosis type 1 and breast cancer is uncommon. In our case series we readdress this association through a literature review.